Your browser doesn't support javascript.
loading
Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial.
Hirai, Keiji; Ookawara, Susumu; Kitano, Taisuke; Miyazawa, Haruhisa; Ito, Kiyonori; Ueda, Yuichirou; Kaku, Yoshio; Hoshino, Taro; Mori, Honami; Yoshida, Izumi; Kubota, Kenji; Yamaji, Yasuyoshi; Takeda, Tetsuro; Nakamura, Yoshikazu; Tabei, Kaoru; Morishita, Yoshiyuki.
Affiliation
  • Hirai K; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Ookawara S; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Kitano T; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Miyazawa H; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Ito K; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Ueda Y; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Kaku Y; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Hoshino T; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Mori H; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Yoshida I; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Kubota K; Department of Nephrology, Saiseikai Kawaguchi General Hospital, Saitama, Japan.
  • Yamaji Y; Saitama Social Insurance Hospital, Saitama, Japan.
  • Takeda T; Department of Nephrology, Dokkyo University Koshigaya Medical Center, Saitama, Japan.
  • Nakamura Y; Department of Public Health, Jichi Medical University, Tochigi, Japan.
  • Tabei K; Department of Internal Medicine, Mimami-uonuma City Hospital, Niigata, Japan.
  • Morishita Y; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Kidney Res Clin Pract ; 36(2): 159-166, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28680823
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Kidney Res Clin Pract Year: 2017 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Kidney Res Clin Pract Year: 2017 Document type: Article Affiliation country: Japan